Premium
Molecular characterization of congenital mesoblastic nephroma and its distinction from wilms Tumor
Author(s) -
Tornlinson Gail E.,
Argyle J. Craig,
Velasco Susana,
Nisen Perry D.
Publication year - 1992
Publication title -
cancer
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.052
H-Index - 304
eISSN - 1097-0142
pISSN - 0008-543X
DOI - 10.1002/1097-0142(19921101)70:9<2358::aid-cncr2820700925>3.0.co;2-f
Subject(s) - wilms' tumor , medicine , pathology
Background . Congenital mesoblastic nephroma (CMN) is a rare tumor of the neonatal kidney. It was once thought to be a variant of Wilms tumor that also arises from primitive renal cells. Methods . Molecular characteristics of two CMN were studied to clarify their potential relationship to Wilms tumors. Patterns of gene expression were assayed by Northern blot hybridization analysis. Tumors were tested for loss of heterozygosity (LOH) at chromosomes 11:13 and 11:15 using Southern blot analysis. Results . The CMN, like Wilms tumors, demonstrated high‐level expression of insulin‐like growth factor 11. Unlike Wilms tumors, however, the CMN expressed neither the N‐myc oncogene nor the putative Wilms tumor suppressor gene, WT1. Using a panel of probes spanning 11:13 and 11:15, no LOH was detected in the CMN, nor was there evidence of deletion or rearrangements of WT1. Conclusions . Although Wilms tumor and CMN both arise from the developing kidney, molecular characterization suggests that different factors are involved in the pathogenesis of these two tumors. Cancer 1992; 70:2358‐2361.